Clinical trial
Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes…
NCT00073255 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00073255 |
|---|---|
| Title | Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM) |
| Official title | Evaluation of Tolerability, Safety, and Pharmacokinetics of hOKT3g1 (Ala-Ala) |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Insulin-Dependent |
| Intervention type | Drug |
| Interventions | hokt3g1 (ALA-ALA) |
| Enrollment | 12 |
| Start date | Jun 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Nov 20, 2003 |
| Last update posted | Jan 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: